492 related articles for article (PubMed ID: 28334716)
1. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.
Ye T; Xu J; Du L; Mo W; Liang Y; Xia J
Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
3. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
4. HSF1 promotes the inhibition of EMT-associated migration by low glucose via directly regulating Snail1 expression in HCC cells.
Liu D; Sun L; Qin X; Liu T; Zhang S; Liu Y; Li S; Guo K
Discov Med; 2016 Sep; 22(120):87-96. PubMed ID: 27755964
[TBL] [Abstract][Full Text] [Related]
5. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.
Xia W; Ma X; Li X; Dong H; Yi J; Zeng W; Yang Z
Oncol Rep; 2015 Aug; 34(2):655-62. PubMed ID: 26035427
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
8. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
9. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
Huang D; Cao L; Zheng S
J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
[TBL] [Abstract][Full Text] [Related]
10. LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition.
Li R; Shang R; Li S; Ren Y; Shen L; Yang L; Chen S; Chen X; Li J; Xu M
Environ Toxicol; 2022 Oct; 37(10):2540-2551. PubMed ID: 35841383
[TBL] [Abstract][Full Text] [Related]
11. LncRNA‑AB209371 promotes the epithelial‑mesenchymal transition of hepatocellular carcinoma cells.
Xiao C; Wan X; Yu H; Chen X; Shan X; Miao Y; Fan R; Cha W
Oncol Rep; 2019 May; 41(5):2957-2966. PubMed ID: 30864719
[TBL] [Abstract][Full Text] [Related]
12. BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.
Han P; Fu Y; Luo M; He J; Liu J; Liao J; Tian D; Yan W
Dig Dis Sci; 2014 May; 59(5):992-1000. PubMed ID: 24442236
[TBL] [Abstract][Full Text] [Related]
13. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
15. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
17. AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway.
Wang M; Zhang L; Liu Z; Zhou J; Pan Q; Fan J; Zang R; Wang L
Cell Death Dis; 2018 Feb; 9(3):324. PubMed ID: 29487329
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Ubiquitin Associated Protein 2-Like (UBAP2L) Inhibits Growth and Metastasis of Hepatocellular Carcinoma.
Li Q; Wang W; Hu YC; Yin TT; He J
Med Sci Monit; 2018 Oct; 24():7109-7118. PubMed ID: 30291221
[TBL] [Abstract][Full Text] [Related]
19. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin Associated Protein 2-Like (UBAP2L) Overexpression in Patients with Hepatocellular Carcinoma and its Clinical Significance.
Wang W; Zhang M; Peng Y; He J
Med Sci Monit; 2017 Oct; 23():4779-4788. PubMed ID: 28981479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]